Early β-blocker therapy for acute myocardial infarction in elderly patients

Annals of Internal Medicine

Volumn 131, Issue 9, 1999, Pages 648-654

  Krumholz, Harlan M ^a   Radford, Martha J ^b   Wang, Yun ^c   Chen, Jersey ^a   Marciniak, Thomas A ^d   Hudson, Barbara ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HEALTH SYSTEM   (United States)

^c Building S2 11 07 ^*

^d CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032751382     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-9-199911020-00003     Document Type: Article

References (21)

1. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog CardiovascDis. 1985:27:335-71.
2. Hjalmarson A, Elmfeldt D. Herlitz J, Holmberg S, Malek I, Nyberg G, et al. Effect on mortality of metoprolol in acute myocardial infarction. A doubleblind randomised trial. Lancet. 19S1;2:823-7.
3. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986:2:57-66.
4. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebocontrolled international trial. The MIAMI Trial Research Group. Eur Heart J. 1985:6:199-226.
5. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med. 1984;310:9-15.
6. Ryan TJ, Anderson JL. Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996:28:1328-428.
7. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996:156:799-805.
8. Berger AK, Edris DW, Breall JA, Oetgen WJ, Marciniak TA, Molinari GF. Resource use and quality of care for Medicare patients with acute myocardial infarction in Maryland and the District of Columbia: analysis of data from the Cooperative Cardiovascular Project. Am Heart J. 1998;135:349-56.
9. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998:280:623-9.
10. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997:277:115-21.
11. National Committee on Quality Assurance. HEDIS 3.0: Health Plan Employer Data and Information Set. Washington. DC: National Committee on Quality Assurance: 1997.
12. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995:273:1509-14.
13. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ. Study outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992:30:377-91.
14. Daley J, Jencks S, Draper D, Lenhart G, Thomas N, Walker J. Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA. 1988:260:3617-24.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985:13:818-29.
16. Bureau of the Census. State and Metropolitan Area Data Book, 1991. Washington, DC: U.S. Government Printing Office; 1991.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982:143:29-36.
18. Hosmer DW, Lemeshow S, Klar J. Goodness-of-fit testing for the logistic regression model when the estimated probabilities are small. Biometrie Journal. 1988:30:911-24.
19. Goldman L, Sia ST, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med. 1988:319:152-7.
20. Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group. Am J Cardiol. 1985;56:15G-22G.
21. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med. 1999:340:286-92.